MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$3,323,384
EPS
-$0.87
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
1,918,424
1,376,861
702,601.5*
922,857
General and administrative
1,743,817
1,715,639
1,761,852.5*
1,020,154
Total operating expenses
3,662,241
3,092,500
2,464,454
1,943,011
Loss from operations
-3,662,241
-3,092,500
-2,464,454*
-1,943,011
Other income (expense), net
338,857
83,449
76,966.5*
35,224
Change in fair value of warrant liability
0
-
-1,175.5*
-611
Total other income (expense), net
338,857
83,449
78,142*
35,835
Net loss
-3,323,384
-3,009,051
-2,386,312*
-1,907,176
Deemed dividends
0
5,681,616
-2,975,764*
2,769,742
Net gain attributable to common stockholders
-3,323,384
-8,690,667
589,452
-4,676,918
Basic EPS
-0.87
-2.71
0.95
-1.77
Diluted EPS
-0.87
-2.71
0.95
-1.77
Basic Average Shares
3,829,363
3,207,720
620,785*
2,644,733
Diluted Average Shares
3,829,363
3,207,720
620,785*
2,644,733
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net gain
attributable to common...
-$3,323,384
(40.93%↑ Y/Y)
Other income
(expense), net
$338,857
(1916.65%↑ Y/Y)
Net loss
-$3,323,384
(-35.96%↓ Y/Y)
Total other income
(expense), net
$338,857
(1911.38%↑ Y/Y)
Loss from operations
-$3,662,241
(-48.80%↓ Y/Y)
Total operating
expenses
$3,662,241
(48.80%↑ Y/Y)
Research and development
$1,918,424
(45.56%↑ Y/Y)
General and
administrative
$1,743,817
(52.53%↑ Y/Y)
Buy us a coffee
REVELATION BIOSCIENCES, INC. (REVBW)
REVELATION BIOSCIENCES, INC. (REVBW)